Dianthus Therapeutics, Inc.
DNTHNASDAQHealthcare● Active
$83.92
+$2.70(+3.32%)
Market Cap$3.5B
P/E Ratio—
52W High$96.5
52W Low$16.64
Dianthus Therapeutics, Inc. (DNTH) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · DNTH · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $404.30M | $275.24M | $173.72M | $75.49M | $176.93M |
| Net Receivables | $0.10M | $0.81M | $0.48M | $5.64M | $0.00M |
| Inventory | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Current Assets | $409.44M | $280.90M | $177.45M | $82.03M | $180.69M |
| PP&E Net | $1.63M | $1.75M | $0.80M | $0.96M | $7.46M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $530.92M | $374.01M | $179.41M | $83.11M | $189.93M |
| Liabilities | |||||
| Short-Term Debt | $0.37M | $0.32M | $0.00M | $0.00M | $0.00M |
| Accounts Payable | $9.72M | $4.58M | $2.61M | $1.17M | $3.04M |
| Total Current Liabilities | $30.73M | $18.45M | $9.63M | $8.22M | $10.86M |
| Long-Term Debt | $1.02M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Liabilities | $37.52M | $21.53M | $10.54M | $9.45M | $17.26M |
| Stockholders Equity | |||||
| Retained Earnings | ($336.73M) | ($174.39M) | ($89.42M) | ($45.87M) | ($325.57M) |
| Total Stockholders Equity | $493.40M | $352.48M | $168.87M | $73.66M | $172.67M |
| Total Liab & Equity(computed) | $530.92M | $374.01M | $179.41M | $83.11M | $189.93M |
| Debt Summary | |||||
| Total Debt | $1.39M | $1.49M | $0.58M | $0.79M | $0.00M |
| Net Debt | ($49.70M) | ($21.30M) | ($131.74M) | ($14.58M) | ($131.65M) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Dianthus Therapeutics, Inc. data
About Dianthus Therapeutics, Inc. (DNTH) Balance Sheet
Dianthus Therapeutics, Inc. (DNTH) balance sheet shows total assets of $0.53B with cash of $0.40B. Total liabilities are $0.04B, total debt $0.00B, and stockholders equity $0.49B.
Frequently asked questions
DNTH · 4 questionsDianthus Therapeutics, Inc. has total debt of $0.00B with net debt of ($0.05B).
DNTH total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10